Newish
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $15M
Investors
- 7
About Newish
, dba Newish, is a biotech company that focuses on developing antitumor DNA vaccine drugs. The company has a GMP new drug pilot plant, a new nucleic acid drug, and a tumor metabolism drug research and development laboratory in the Beijing Economic and Technological Development Zone. The company has acquired more than 40 patents. The company has acquired the Excellent Enterprise Award. The company has built two in-house technology platforms, including STARi (Super Targeting Activated Response of immunization) platform and the Newish T-cell therapeutic platform. The STARi platform is an ultra-targeted nucleic acid drug platform that activates T-cell immune responses for the development of various tumor vaccine products. The company generates revenue by developing pharmacies.
Who invested in Newish
7 investors across 3 rounds
See all investors in Newish
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Newish
Who invested in Newish?
Newish has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Newish raised?
Newish has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Newish last raise money?
Newish's most recent round on record is a Series B, in Jun 2026.
What does Newish do?
, dba Newish, is a biotech company that focuses on developing antitumor DNA vaccine drugs.
Where is Newish headquartered?
Newish is headquartered in Beijing, China.
Which VCs invest in companies like Newish?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Newish's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Newish? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.